title: Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains.
abstract: Coronaviruses (CoVs) and low-pathogenicity influenza A viruses (LP IAVs) depend on target cell proteases to cleave their viral glycoproteins and prime them for virus-cell membrane fusion. Several proteases cluster into tetraspanin-enriched microdomains (TEMs), suggesting that TEMs are preferred virus entry portals. Here we found that several CoV receptors and virus-priming proteases were indeed present in TEMs. Isolated TEMs, when mixed with CoV and LP IAV pseudoparticles, cleaved viral fusion proteins to fusion-primed fragments and potentiated viral transductions. That entering viruses utilize TEMs as a protease source was further confirmed using tetraspanin antibodies and tetraspanin short hairpin RNAs (shRNAs). Tetraspanin antibodies inhibited CoV and LP IAV infections, but their virus-blocking activities were overcome by expressing excess TEM-associated proteases. Similarly, cells with reduced levels of the tetraspanin CD9 resisted CoV pseudoparticle transductions but were made susceptible by overproducing TEM-associated proteases. These findings indicated that antibodies and CD9 depletions interfere with viral proteolytic priming in ways that are overcome by surplus proteases. TEMs appear to be exploited by some CoVs and LP IAVs for appropriate coengagement with cell receptors and proteases.
  
  
  OBJECTIVE
  Enveloped viruses use their surface glycoproteins to catalyze membrane fusion, an essential cell entry step. Host cell components prime these viral surface glycoproteins to catalyze membrane fusion at specific times and places during virus cell entry. Among these priming components are proteases, which cleave viral surface glycoproteins, unleashing them to refold in ways that catalyze virus-cell membrane fusions. For some enveloped viruses, these proteases are known to reside on target cell surfaces. This research focuses on coronavirus and influenza A virus cell entry and identifies TEMs as sites of viral proteolysis, thereby defining subcellular locations of virus priming with greater precision. Implications of these findings extend to the use of virus entry antagonists, such as protease inhibitors, which might be most effective when localized to these microdomains.
authors.affiliation: Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois, USA.
authors.forename: James T
authors.initials: JT
authors.lastname: Earnest
authors.affiliation: Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois, USA.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Hantak
authors.affiliation: Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois, USA.
authors.forename: Jung-Eun
authors.initials: JE
authors.lastname: Park
authors.affiliation: Department of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois, USA tgallag@luc.edu.
authors.forename: Tom
authors.initials: T
authors.lastname: Gallagher
mesh_terms: D000818:Animals; D017934:Coronavirus / Q000502:physiology*; D006801:Humans; D009980:Influenza A virus / Q000502:physiology*; D021962:Membrane Microdomains / Q000737:chemistry / Q000378:metabolism / Q000821:virology*; D010447:Peptide Hydrolases / Q000032:analysis; D059748:Proteolysis; D011991:Receptors, Virus / Q000032:analysis; D059470:Tetraspanins / Q000378:metabolism*; D014760:Viral Fusion Proteins / Q000378:metabolism; D053585:Virus Attachment; D053586:Virus Internalization
chemical_list: D011991:Receptors, Virus; D059470:Tetraspanins; D014760:Viral Fusion Proteins; D010447:Peptide Hydrolases
references.citation: Microbes Infect. 2010 Feb;12(2):106-12
references.pmid: 19896556
references.citation: Nature. 2010 Feb 11;463(7282):813-7
references.pmid: 20027183
references.citation: J Virol. 2010 Apr;84(8):4041-9
references.pmid: 20130047
references.citation: J Virol. 2010 Jun;84(11):5605-14
references.pmid: 20237084
references.citation: J Biol Chem. 2000 Jun 9;275(23):17221-4
references.pmid: 10770957
references.citation: PLoS One. 2014;9(1):e86671
references.pmid: 24466195
references.citation: Nat Commun. 2014;5:3067
references.pmid: 24473083
references.citation: Viruses. 2014;6(3):1078-90
references.pmid: 24608085
references.citation: J Virol. 2014 May;88(9):4953-61
references.pmid: 24554656
references.citation: Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9
references.pmid: 25288733
references.citation: J Virol. 2006 Oct;80(19):9896-8
references.pmid: 16973594
references.citation: Proteomics. 2006 Dec;6(24):6447-54
references.pmid: 17109380
references.citation: EMBO J. 2001 May 15;20(10):2443-53
references.pmid: 11350933
references.citation: J Biol Chem. 2001 Mar 16;276(11):7974-84
references.pmid: 11113129
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9642-7
references.pmid: 11493690
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10642-7
references.pmid: 11535814
references.citation: Eur J Immunol. 2003 Sep;33(9):2479-89
references.pmid: 12938224
references.citation: J Biol Chem. 2003 Oct 24;278(43):41624-30
references.pmid: 12913001
references.citation: J Virol. 2003 Dec;77(23):12543-51
references.pmid: 14610177
references.citation: Nature. 2003 Nov 27;426(6965):450-4
references.pmid: 14647384
references.citation: J Virol. 2004 Mar;78(6):2682-92
references.pmid: 14990688
references.citation: Glycoconj J. 2004;20(1):71-8
references.pmid: 14993838
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60
references.pmid: 15150417
references.citation: J Virol. 2004 Aug;78(16):8701-8
references.pmid: 15280478
references.citation: J Biol Chem. 1991 Oct 15;266(29):19599-610
references.pmid: 1918067
references.citation: J Virol. 1991 Dec;65(12):6881-91
references.pmid: 1719235
references.citation: Nature. 1992 Jun 4;357(6377):420-2
references.pmid: 1350662
references.citation: J Biol Chem. 1992 Jul 5;267(19):13573-9
references.pmid: 1618859
references.citation: Cancer Res. 1999 Sep 1;59(17):4180-4
references.pmid: 10485450
references.citation: J Biol Chem. 2005 Apr 22;280(16):16227-34
references.pmid: 15710618
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81
references.pmid: 16081529
references.citation: Nat Rev Mol Cell Biol. 2005 Oct;6(10):801-11
references.pmid: 16314869
references.citation: Mol Cell Biol. 2006 Feb;26(3):965-75
references.pmid: 16428450
references.citation: J Cell Sci. 2006 Feb 1;119(Pt 3):416-24
references.pmid: 16418227
references.citation: Proteomics. 2006 Mar;6(5):1437-49
references.pmid: 16404722
references.citation: J Virol. 2006 Jun;80(12):5768-76
references.pmid: 16731916
references.citation: J Biol Chem. 2006 Jul 14;281(28):19665-75
references.pmid: 16690612
references.citation: J Virol. 2006 Sep;80(17):8695-704
references.pmid: 16912317
references.citation: Semin Cancer Biol. 2010 Jun;20(3):161-8
references.pmid: 20470890
references.citation: J Virol Methods. 2010 Nov;169(2):365-74
references.pmid: 20709108
references.citation: J Virol. 2010 Dec;84(24):12658-64
references.pmid: 20926566
references.citation: Int J Biochem Cell Biol. 2011 Jan;43(1):106-19
references.pmid: 20937409
references.citation: J Virol. 2011 Jan;85(2):873-82
references.pmid: 21068237
references.citation: Virol J. 2011;8:27
references.pmid: 21251300
references.citation: J Virol. 2011 May;85(9):4122-34
references.pmid: 21325420
references.citation: PLoS One. 2011;6(8):e23261
references.pmid: 21853097
references.citation: Antiviral Res. 2011 Oct;92(1):27-36
references.pmid: 21802447
references.citation: J Biol Chem. 2011 Dec 9;286(49):42141-9
references.pmid: 21994935
references.citation: PLoS One. 2012;7(4):e35876
references.pmid: 22558251
references.citation: J Virol. 2012 Jun;86(12):6537-45
references.pmid: 22496216
references.citation: J Virol. 2013 Mar;87(6):3435-46
references.pmid: 23302890
references.citation: Nature. 2013 Mar 14;495(7440):251-4
references.pmid: 23486063
references.citation: J Virol. 2013 May;87(10):5502-11
references.pmid: 23468491
references.citation: J Virol. 2013 Jun;87(11):6150-60
references.pmid: 23536651
references.citation: J Virol. 2013 Aug;87(15):8272-81
references.pmid: 23698304
references.citation: J Biol Chem. 2013 Aug 30;288(35):25490-9
references.pmid: 23864655
references.citation: PLoS Pathog. 2013;9(10):e1003701
references.pmid: 24130495
references.citation: J Virol. 2013 Dec;87(23):12552-61
references.pmid: 24027332
references.citation: PLoS Pathog. 2013;9(12):e1003774
references.pmid: 24348248
references.citation: J Virol. 2014 Jan;88(2):1293-307
references.pmid: 24227843
references.citation: Dev Biol. 2007 Apr 1;304(1):317-25
references.pmid: 17239847
references.citation: Virology. 2007 Apr 10;360(2):286-93
references.pmid: 17123568
references.citation: Curr Protoc Microbiol. 2006 Dec;Chapter 15:Unit 15G.1
references.pmid: 18770580
references.citation: J Virol. 2009 Jan;83(2):712-21
references.pmid: 18971274
references.citation: Biochem J. 2009 Jun 1;420(2):133-54
references.pmid: 19426143
references.citation: Virol J. 2009;6:76
references.pmid: 19515258
references.citation: J Biol Chem. 2009 Aug 28;284(35):23177-81
references.pmid: 19487698
references.citation: Trends Cell Biol. 2009 Sep;19(9):434-46
references.pmid: 19709882
references.citation: J Biol Chem. 2009 Nov 20;284(47):32725-34
references.pmid: 19801669